Cilastatin
CHEBI:CHEBI_3697
Definition
The thioether resulting from the formal oxidative coupling of the thiol group of L-cysteine with the 7-position of (2Z)-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid. It is an inhibitor of dehydropeptidase I (membrane dipeptidase, 3.4.13.19), an enzyme found in the brush border of renal tubes and responsible for degrading the antibiotic imipenem. Cilastatin is therefore administered (as the sodium salt) with imipenem to prolong the antibacterial effect of the latter by preventing its renal metabolism to inactive and potentially nephrotoxic products. Cilastatin also acts as a leukotriene D4 dipeptidase inhibitor, preventing the metabolism of leukotriene D4 to leukotriene E4.
Chemical Information
- Molecular Formula
- C16H26N2O5S
- Molecular Mass
- 358.45300
- Charge
- 0
- SMILES
- CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@H](N)C(O)=O
- InChI
- InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1
- InChIKey
- DHSUYTOATWAVLW-WFVMDLQDSA-N
Alternative Names
- (2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid
- (L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
- (Z)-(S)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine
- (Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
- cilastatin
- cilastatina
- cilastatine
- cilastatinum
Drug Classification
-
carboxamideView Class →
CHEBI:37622
-
non-proteinogenic L-alpha-amino acidView Class →
CHEBI:83822
-
organic sulfideView Class →
CHEBI:16385
-
L-cysteine derivativeView Class →
CHEBI:83824
-
t206679
-
t207192
-
t207226
-
t207502
-
t207627
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2540
- oboInOwl#hasDbXref
- Wikipedia:Cilastatin
- core#notation
- CHEBI:3697
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2540
- oboInOwl#hasDbXref
- Wikipedia:Cilastatin
- oboInOwl#hasAlternativeId
- CHEBI:41538
- oboInOwl#id
- CHEBI:3697
- core#notation
- CHEBI:3697
- listing_expiration_date
- 20251231
- dosage_form
- POWDER
- marketing_start_date
- 20150824
- product_type
- BULK INGREDIENT
- marketing_category
- EXPORT ONLY
- active_ingredient_strength
- 1 kg/kg
- package_marketing_start_date
- 07-OCT-22
- generic_name
- Cilastatin Sodium
- active_ingredient_name
- CILASTATIN SODIUM
- product_ndc
- 69806-0094
- labeler_name
- Merck Sharp & Dohme Corp.
- spl_id
- 87a8ac0f-e586-447a-abf6-611db2a11f9f
- package_ndc
- 69806-0094-0
- package_description
- 1 CAN in 1 BOX (69806-0094-0) / 12 kg in 1 CAN
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_76926
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_59512
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect22338
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_59512
- owl#annotatedSource
- t207592
- owl#someValuesFrom
- t3444752